rho GTPase Activating Protein 2 (ARHGAP2) (C-Term) Peptide
Quick Overview for rho GTPase Activating Protein 2 (ARHGAP2) (C-Term) Peptide (ABIN974934)
Target
Origin
Source
Application
-
-
Protein Region
- C-Term
-
Sequence
- LITYDAYPKF IESAKIMDPD EQLETLHEAL KLLPPAHCET LRYLMAHLKR
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-CHN1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- CHN1 (ARHGAP2) (rho GTPase Activating Protein 2 (ARHGAP2))
-
Background
-
This gene encodes GTPase-activating protein for ras-related p21-rac and a phorbol ester receptor. It is predominantly expressed in neurons, and plays an important role in neuronal signal-transduction mechanisms. Mutations in this gene are associated with Duane's retraction syndrome 2 (DURS2). Alternatively spliced transcript variants encoding different isoforms have been described for this gene.
Alias Symbols: ARHGAP2, CHN, DURS2, RHOGAP2, NC
Protein Size: 334 -
Molecular Weight
- 36 kDa
-
Gene ID
- 1123
-
NCBI Accession
- NM_001206602, NP_001193531
Target
-